NO133670C - - Google Patents

Info

Publication number
NO133670C
NO133670C NO430/73A NO43073A NO133670C NO 133670 C NO133670 C NO 133670C NO 430/73 A NO430/73 A NO 430/73A NO 43073 A NO43073 A NO 43073A NO 133670 C NO133670 C NO 133670C
Authority
NO
Norway
Application number
NO430/73A
Other languages
Norwegian (no)
Other versions
NO133670B (US20050192411A1-20050901-C00001.png
Inventor
E Mago
T Balogh
E Uskert
J Borsi
L Wolf
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HUGO001186 external-priority patent/HU164051B/hu
Priority claimed from HUGO001187 external-priority patent/HU163546B/hu
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of NO133670B publication Critical patent/NO133670B/no
Publication of NO133670C publication Critical patent/NO133670C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06Lysergic acid amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06Lysergic acid amides
    • C07D457/08Lysergic acid amides in which the amide nitrogen is a member of a heterocyclic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO430/73A 1972-02-04 1973-02-02 NO133670C (US20050192411A1-20050901-C00001.png)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HUGO001186 HU164051B (US20050192411A1-20050901-C00001.png) 1972-02-04 1972-02-04
HUGO001187 HU163546B (US20050192411A1-20050901-C00001.png) 1972-02-04 1972-02-04

Publications (2)

Publication Number Publication Date
NO133670B NO133670B (US20050192411A1-20050901-C00001.png) 1976-03-01
NO133670C true NO133670C (US20050192411A1-20050901-C00001.png) 1976-06-09

Family

ID=26318474

Family Applications (1)

Application Number Title Priority Date Filing Date
NO430/73A NO133670C (US20050192411A1-20050901-C00001.png) 1972-02-04 1973-02-02

Country Status (20)

Country Link
JP (1) JPS5221516B2 (US20050192411A1-20050901-C00001.png)
AU (1) AU475943B2 (US20050192411A1-20050901-C00001.png)
BE (1) BE794888A (US20050192411A1-20050901-C00001.png)
BG (1) BG22832A3 (US20050192411A1-20050901-C00001.png)
CA (1) CA994342A (US20050192411A1-20050901-C00001.png)
CH (1) CH589079A5 (US20050192411A1-20050901-C00001.png)
CS (1) CS191212B2 (US20050192411A1-20050901-C00001.png)
DD (1) DD104299A5 (US20050192411A1-20050901-C00001.png)
DE (1) DE2305514A1 (US20050192411A1-20050901-C00001.png)
DK (1) DK141531B (US20050192411A1-20050901-C00001.png)
EG (1) EG10823A (US20050192411A1-20050901-C00001.png)
FI (1) FI54118C (US20050192411A1-20050901-C00001.png)
FR (1) FR2190440B1 (US20050192411A1-20050901-C00001.png)
GB (1) GB1401155A (US20050192411A1-20050901-C00001.png)
IL (1) IL41409A (US20050192411A1-20050901-C00001.png)
NL (1) NL178256C (US20050192411A1-20050901-C00001.png)
NO (1) NO133670C (US20050192411A1-20050901-C00001.png)
SE (1) SE421424B (US20050192411A1-20050901-C00001.png)
SU (1) SU468419A3 (US20050192411A1-20050901-C00001.png)
YU (1) YU36730B (US20050192411A1-20050901-C00001.png)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU169073B (US20050192411A1-20050901-C00001.png) * 1974-05-28 1976-09-28
HU168914B (US20050192411A1-20050901-C00001.png) * 1974-07-30 1976-08-28
HU172649B (hu) * 1975-04-24 1978-11-28 Gyogyszerkutato Intezet Sposob poluchenija novykh biologicheski aktivnykh lizergamidov
DE2802023A1 (de) * 1977-01-28 1978-08-03 Sandoz Ag Neue ergotderivate, ihre herstellung und verwendung
JPH0438472U (US20050192411A1-20050901-C00001.png) * 1990-07-31 1992-03-31
IT1260156B (it) * 1992-08-03 1996-03-28 Fidia Spa Derivati dell'acido neuraminico
KR20140042868A (ko) * 2011-06-23 2014-04-07 맵 파마슈티컬스, 인코포레이티드 신규한 플루오로에르골린 유사체

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH475252A (de) * 1966-02-08 1969-07-15 Sandoz Ag Verfahren zur Herstellung neuer Lysergsäure-Derivate
AT291446B (de) * 1968-11-22 1971-07-12 Richter Gedeon Vegyeszet Verfahren zur Herstellung von neuen Apovincaminsäureamiden

Also Published As

Publication number Publication date
JPS4886900A (US20050192411A1-20050901-C00001.png) 1973-11-15
YU26673A (en) 1982-02-25
DD104299A5 (US20050192411A1-20050901-C00001.png) 1974-03-05
AU5163373A (en) 1974-08-01
FI54118B (fi) 1978-06-30
DK141531C (US20050192411A1-20050901-C00001.png) 1980-10-06
EG10823A (en) 1976-07-31
SU468419A3 (ru) 1975-04-25
IL41409A (en) 1977-04-29
BE794888A (fr) 1973-05-29
BG22832A3 (bg) 1977-04-20
NL178256B (nl) 1985-09-16
SE421424B (sv) 1981-12-21
NL7301369A (US20050192411A1-20050901-C00001.png) 1973-08-07
IL41409A0 (en) 1973-03-30
GB1401155A (en) 1975-07-16
YU36730B (en) 1984-08-31
CH589079A5 (US20050192411A1-20050901-C00001.png) 1977-06-30
AU475943B2 (en) 1976-09-09
DE2305514A1 (de) 1973-08-16
JPS5221516B2 (US20050192411A1-20050901-C00001.png) 1977-06-10
FI54118C (fi) 1978-10-10
FR2190440A1 (US20050192411A1-20050901-C00001.png) 1974-02-01
FR2190440B1 (US20050192411A1-20050901-C00001.png) 1976-09-03
DK141531B (da) 1980-04-14
CS191212B2 (en) 1979-06-29
NL178256C (nl) 1986-02-17
CA994342A (en) 1976-08-03
NO133670B (US20050192411A1-20050901-C00001.png) 1976-03-01

Similar Documents

Publication Publication Date Title
CS174206B2 (US20050192411A1-20050901-C00001.png)
CS173648B2 (US20050192411A1-20050901-C00001.png)
DK141531C (US20050192411A1-20050901-C00001.png)
CS171746B2 (US20050192411A1-20050901-C00001.png)
JPS5245114B2 (US20050192411A1-20050901-C00001.png)
JPS4894732U (US20050192411A1-20050901-C00001.png)
JPS49104580U (US20050192411A1-20050901-C00001.png)
CS172483B1 (US20050192411A1-20050901-C00001.png)
CS165917B1 (US20050192411A1-20050901-C00001.png)
CS156329B1 (US20050192411A1-20050901-C00001.png)
CS156687B1 (US20050192411A1-20050901-C00001.png)
CS155444B1 (US20050192411A1-20050901-C00001.png)
CS154504B1 (US20050192411A1-20050901-C00001.png)
JPS4882852A (US20050192411A1-20050901-C00001.png)
CS157994B1 (US20050192411A1-20050901-C00001.png)
CS154093B1 (US20050192411A1-20050901-C00001.png)
JPS4925977A (US20050192411A1-20050901-C00001.png)
JPS4963716A (US20050192411A1-20050901-C00001.png)
CS159442B1 (US20050192411A1-20050901-C00001.png)
CS160852B1 (US20050192411A1-20050901-C00001.png)
CS156012B1 (US20050192411A1-20050901-C00001.png)
CS174209B2 (US20050192411A1-20050901-C00001.png)
CH1486873A4 (US20050192411A1-20050901-C00001.png)
BG18059A1 (US20050192411A1-20050901-C00001.png)
BG18373A1 (US20050192411A1-20050901-C00001.png)